This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2. GS Hotamisligil (2006) Inflammation and metabolic disorders. Nature 444, 860–867.
5. HS Park , JY Park & R Yu (2005) Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Res Clin Pract 69, 29–35.
6. M Bulló , P García-Lorda , I Megias (2003) Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 11, 525–531.
9. BL Wajchenberg (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21, 697–738.
11. Z Quijada , M Paoli , Y Zerpa (2008) The triglyceride/HDL-cholesterol ratio as a marker of cardiovascular risk in obese children; association with traditional and emergent risk factors. Pediatr Diabetes 9, 464–471.
15. A Gupta , S Ten & H Anhalt (2005) Serum levels of soluble tumor necrosis factor-alpha receptor 2 are linked to insulin resistance and glucose intolerance in children. J Pediatr Endocrinol Metab 18, 75–82.
18. RJ Gøbel , SM Jensen , H Frøkiaer (2012) Obesity, inflammation and metabolic syndrome in Danish adolescents. Acta Paediatr 101(2), 192–200.
20. D Martínez-Gómez , JC Eisenmann , JA Wärnberg (2010) Associations of physical activity, fitness and fatness with low-grade inflammation in adolescents. The AFINOS study. Int J Obes (London) 34, 1501–1507.
21. JR Ruiz , FB Ortega , J Warnberg (2007) Associations of low-grade inflammation with physical activity, fitness and fatness in prepubertal children; the European Youth Heart Study. Int J Obes (Lond) 31, 1545–1551.
22. J Romeo , D Martínez-Gómez , LE Díaz (2011) Changes in cardiometabolic risk factors, appetite-controlling hormones and cytokines after a treatment programme in overweight adolescents: preliminary findings from the EVASYON study. Pediatric Diabetes 12, 372–380.
23. A Martí , A Marcos & JA Martínez (2001) Obesity and immune function relationships. Obes Rev 2, 131–140.
25. S Caspar-Bauguil , B Cousin , A Galinier (2005) Adipose tissues as an ancestral immune organ: site-specific change in obesity. FEBS Lett 579, 3487–3492.
26. CH Saely , K Geiger & H Drexel (2010) Brown versus white adipose tissue: a mini-review. Gerontology 58(1), 15–23.
27. S Poglio , F de Toni-Costes , E Arnaud (2010) Adipose tissue as a dedicated reservoir of functional mast cell progenitors. Stem Cells 28, 2065–2072.
28. SP Weisberg , D McCann , M Desai (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796–1808.
29. CN Lumeng , JL Bodzin & AR Saltiel (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117, 175–184.
33. A Koerner , J Kratzsch & W Kiess (2005) Adipocytokines: leptin – the classical, resistin – the controversial, adiponectin – the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19, 525–546.
35. KH Pietiläinen , T Róg , T Seppänen-Laakso (2011) Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 9, e1000623.
36. C Stryjecki & DM Mutch (2011) Fatty acid-gene interactions, adipokines and obesity. Eur J Clin Nutr 65, 285–297.
38. JM Fernández-Real , J Vendrell & W Ricart (2005) Circulating adiponectin and plasma fatty acid profile. Clin Chem 51, 603–609.
39. F Pérez de Heredia , J Sánchez , T Priego (2009) Adiponectin is associated with serum and adipose tissue fatty acid composition in rats. J Endocrinol Invest 32, 659–665.
41. MB Fessler , LL Rudel & JM Brown (2009) Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol 20, 379–385.
43. M Mei , L Zhao , Q Li (2011) Inflammatory stress exacerbates ectopic lipid deposition in C57BL/6J mice. Lipids Health Dis 10, 1–10 (Epublication ahead of print version).
44. MF Gregor & GS Hotamisligil (2007) Thematic review series: Adipocyte biology. adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res 48, 1905–1914.
45. P Trayhurn , F Pérez de Heredia , B Wang (2010) Hypoxia – role in adipocyte function and dysfunction. In Novel Insight into Adipose Cell Functions, pp. 45–60 [ K Clément , BM Spiegelman and Y Christen , editors]. Berlin, Heidelberg: Springer-Verlag.
46. F Pérez de Heredia , IS Wood & P Trayhurn (2010) Hypoxia stimulates lactate release and modulates monocarboxylate transporter (MCT1, MCT2, MCT4) expression in human adipocytes. Pflüg Arch – Eur J Physiol 459, 509–518.
47. DJ Samuvel , KP Sundararaj , A Nareika (2009) Lactate boosts TLR4 signaling and NF-ΚB pathway-mediated gene transcription in macrophages via monocarboxylate transporters and MD-2 up-regulation. J Immunol 182, 2476–2484.
49. N Halberg , T Khan , ME Trujillo (2009) Hypoxia-inducible factor 1α induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 29, 4467–4483.
50. R Cancello , J Tordjman , C Poitou (2006) Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55, 1554–1561.
51. JJ Hernández-Morante , F Milagro , JA Gabaldón (2006) Effect of DHEA-sulfate on adiponectin gene expression in adipose tissue from different fat depots in morbidly obese humans. Eur J Endocrinol 155, 593–600.
52. A Villaret , J Galitzky , P Decaunes (2010) Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes 59, 2755–2763.